Shandong Xinhua Pharmaceutical Co. Ltd. reported unaudited consolidated earnings results for the six months ended June 30, 2018. For the six months, the company reported total operating income of RMB 2,687,680,140.23 against RMB 2,403,274,161.26 a year ago. Operating profit was RMB 166,133,634.82 against RMB 149,498,274.13 a year ago. Total profit was RMB 163,340,602.00 against RMB 147,562,389.11 a year ago. Net profit was RMB 133,844,607.25 against RMB 114,039,862.26 a year ago. Net profit attributable to shareholders of parent company was RMB 123,363,815.34 against RMB 106,774,952.86 a year ago. Basic and diluted earnings per share were RMB 0.26 against RMB 0.23 a year ago. Net cash flow from operating activities of the Group for the first half of 2018 was approximately RMB 136,331,000, representing an increase by RMB 126,774,000 as compared with the same period last year.